KBC Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Sell |
3,898
-884
| -18% | -$28.8K | ﹤0.01% | 1068 |
|
|
2025
Q1 | $181K | Buy |
4,782
+7
| +0.1% | +$265 | ﹤0.01% | 1140 |
|
|
2024
Q4 | $391K | Buy |
4,775
+2,092
| +78% | +$171K | ﹤0.01% | 858 |
|
|
2024
Q3 | $307K | Buy |
2,683
+322
| +14% | +$36.8K | ﹤0.01% | 790 |
|
|
2024
Q2 | $178K | Buy |
2,361
+351
| +17% | +$26.5K | ﹤0.01% | 904 |
|
|
2024
Q1 | $137K | Buy |
2,010
+472
| +31% | +$32.2K | ﹤0.01% | 986 |
|
|
2023
Q4 | $97K | Hold |
1,538
| – | – | ﹤0.01% | 1080 |
|
|
2023
Q3 | $78K | Buy |
+1,538
| New | +$78K | ﹤0.01% | 1123 |
|